After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction.

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

A high school student found a way to run the classic PC game Doom from within a PDF file by leveraging the format's support for JavaScript and the Chromium browser engine.

There is a race to see who can bend the PDF file format to do the most impressive thing. Considering the more-than-30-year-old shooter, Doom, has been ported to many unexpected places, it was ...

RALEIGH, N.C. (January 13, 2025) – The first group of apprentices has officially signed on with Amgen in a unique program that will prepare a skilled workforce for the biopharmaceutical leader's ...

Sling Therapeutics’ oral challenger to Amgen’s intravenous Tepezza has hit ... the response rates in the two Tepezza trials were (PDF) 71% and 83%. Cross-trial comparisons can be misleading ...

The latest trading session saw Amgen (AMGN) ending at $267.10, denoting a -1.14% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.12% for the ...

A biotech stock index slid by almost 3%. Amgen is one of those would-be competitors and, at the JPM meeting, executives defended recent trial results for the company’s rival weight loss drug.